# Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

> **NCT02189850** · PHASE2 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 29 (actual)

## Conditions studied

- Colonoscopy

## Interventions

- **DRUG:** BLI800 - Dose 1
- **DRUG:** BLI800 - Dose 2

## Key facts

- **NCT ID:** NCT02189850
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189850, "Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02189850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*